http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H1045726-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b09f893b262cefd50c5e76c4b85d1c0a |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-24 |
| filingDate | 1997-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7592afd51921cdd37a0b84dcb0f4db01 |
| publicationDate | 1998-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H1045726-A |
| titleOfInvention | Method for producing optically active piperazine-2-carboxylic acid derivative |
| abstract | PROBLEM TO BE SOLVED: To provide an optically active piperazinecarboxylic acid derivative represented by the following general formula: Wherein X is an alkoxy or (substituted) amino group. ] Is provided. The compounds of the above general formula are intermediates for producing pharmacologically active substances, for example, HIV protease inhibitors. SOLUTION: The corresponding pyrazinecarboxylic acid derivative is Asymmetric hydrogenation under the catalysis of an optically active rhodium complex. |
| priorityDate | 1996-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.